Comments
Loading...
Beauty Health Analyst Ratings and Price Targets | NASDAQ:SKIN | Benzinga
The Beauty Health Co has a consensus price target of $6.44 based on the ratings of 14 analysts. The high is $19 issued by Goldman Sachs on November 23, 2022. The low is $1 issued by Piper Sandler on August 9, 2024. The 3 most-recent analyst ratings were released by Canaccord Genuity on March 13, 2025, November 13, 2024, and August 12, 2024, respectively. With an average price target of $1.5 between Canaccord Genuity, there's an implied 47.78% upside for The Beauty Health Co from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Canaccord Genuity
Piper Sandler
Stifel
DA Davidson
TD Cowen
1calculated from analyst ratings
Analyst Ratings for Beauty Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/13/2025 | Buy Now | 47.78% | Canaccord Genuity | Susan Anderson65% | $1.75 → $1.5 | Maintains | Hold | Get Alert |
| 11/13/2024 | Buy Now | 72.41% | Canaccord Genuity | Susan Anderson65% | $1.25 → $1.75 | Maintains | Hold | Get Alert |
| 08/12/2024 | Buy Now | 23.15% | Canaccord Genuity | Susan Anderson65% | $2 → $1.25 | Maintains | Hold | Get Alert |
| 08/09/2024 | Buy Now | -1.48% | Piper Sandler | Korinne Wolfmeyer47% | $1.5 → $1 | Reiterates | Underweight → Underweight | Get Alert |
| 07/26/2024 | Buy Now | 97.04% | Stifel | Jonathan Block71% | $4 → $2 | Maintains | Hold | Get Alert |
| 07/11/2024 | Buy Now | 47.78% | Piper Sandler | Korinne Wolfmeyer47% | $2.5 → $1.5 | Maintains | Underweight | Get Alert |
| 05/13/2024 | Buy Now | 392.61% | DA Davidson | Linda Bolton Weiser53% | $5 → $5 | Maintains | Buy | Get Alert |
| 05/13/2024 | Buy Now | 195.57% | TD Cowen | Oliver Chen53% | $4 → $3 | Maintains | Hold | Get Alert |
| 05/10/2024 | Buy Now | 146.31% | Piper Sandler | Korinne Wolfmeyer47% | $3 → $2.5 | Maintains | Underweight | Get Alert |
| 03/15/2024 | Buy Now | 392.61% | DA Davidson | Linda Bolton Weiser53% | $5 → $5 | Maintains | Buy | Get Alert |
| 03/14/2024 | Buy Now | 294.09% | Canaccord Genuity | Susan Anderson65% | $3 → $4 | Maintains | Hold | Get Alert |
| 03/13/2024 | Buy Now | 195.57% | Piper Sandler | Korinne Wolfmeyer47% | $2 → $3 | Reiterates | Underweight → Underweight | Get Alert |
| 03/13/2024 | Buy Now | 294.09% | Stifel | Jonathan Block71% | $3 → $4 | Reiterates | Hold → Hold | Get Alert |
| 03/13/2024 | Buy Now | 294.09% | TD Cowen | Oliver Chen53% | $2.5 → $4 | Maintains | Market Perform | Get Alert |
| 02/29/2024 | Buy Now | 195.57% | Canaccord Genuity | Susan Anderson65% | $2.5 → $3 | Maintains | Hold | Get Alert |
| 11/15/2023 | Buy Now | 47.78% | Jefferies | Ashley Helgans26% | $11 → $1.5 | Downgrade | Buy → Hold | Get Alert |
| 11/14/2023 | Buy Now | 195.57% | Stifel | Jonathan Block71% | $8 → $3 | Maintains | Hold | Get Alert |
| 11/14/2023 | Buy Now | — | Benchmark | Bruce Jackson39% | — | Downgrade | Buy → Hold | Get Alert |
| 11/14/2023 | Buy Now | — | William Blair | Margaret Kaczor36% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/14/2023 | Buy Now | 146.31% | TD Cowen | Oliver Chen53% | $9 → $2.5 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/14/2023 | Buy Now | — | Raymond James | Olivia Tong67% | — | Downgrade | Market Perform → Underperform | Get Alert |
| 11/14/2023 | Buy Now | 97.04% | Piper Sandler | Korinne Wolfmeyer47% | $12 → $2 | Downgrade | Overweight → Underweight | Get Alert |
| 11/14/2023 | Buy Now | 146.31% | Canaccord Genuity | Susan Anderson65% | $10 → $2.5 | Downgrade | Buy → Hold | Get Alert |
| 11/14/2023 | Buy Now | — | JP Morgan | Allen Gong38% | — | Downgrade | Neutral → Underweight | Get Alert |
| 09/13/2023 | Buy Now | 2166.01% | Benchmark | Bruce Jackson39% | → $23 | Reiterates | Buy → Buy | Get Alert |
| 08/25/2023 | Buy Now | 885.22% | Canaccord Genuity | Kyle Rose67% | → $10 | Assumes | → Buy | Get Alert |
| 08/10/2023 | Buy Now | 786.7% | TD Cowen | Oliver Chen53% | $15 → $9 | Maintains | Outperform | Get Alert |
| 08/10/2023 | Buy Now | 1525.62% | DA Davidson | Linda Bolton Weiser53% | $35 → $16.5 | Maintains | Buy | Get Alert |
| 08/08/2023 | Buy Now | 2166.01% | Benchmark | Bruce Jackson39% | → $23 | Reiterates | Buy → Buy | Get Alert |
| 06/21/2023 | Buy Now | 885.22% | Stifel | Jonathan Block71% | $17 → $10 | Downgrade | Buy → Hold | Get Alert |
| 05/26/2023 | Buy Now | 1082.27% | JP Morgan | Allen Gong38% | $13 → $12 | Maintains | Neutral | Get Alert |
| 05/18/2023 | Buy Now | 2166.01% | Benchmark | Bruce Jackson39% | → $23 | Reiterates | Buy → Buy | Get Alert |
| 05/11/2023 | Buy Now | 3348.28% | DA Davidson | Linda Bolton Weiser53% | → $35 | Reiterates | → Buy | Get Alert |
| 03/28/2023 | Buy Now | 1673.4% | Canaccord Genuity | Kyle Rose67% | → $18 | Reiterates | → Buy | Get Alert |
| 03/20/2023 | Buy Now | — | Exane BNP Paribas | Navaan Ty1% | — | Upgrade | Underperform → Neutral | Get Alert |
| 03/14/2023 | Buy Now | 2166.01% | Benchmark | Bruce Jackson39% | → $23 | Reiterates | → Buy | Get Alert |
| 03/01/2023 | Buy Now | 3348.28% | DA Davidson | Linda Bolton Weiser53% | $32 → $35 | Maintains | Buy | Get Alert |
| 02/28/2023 | Buy Now | 2166.01% | Benchmark | Bruce Jackson39% | → $23 | Reiterates | → Buy | Get Alert |
| 02/16/2023 | Buy Now | 1377.83% | Cowen & Co. | Oliver Chen53% | $20 → $15 | Maintains | Outperform | Get Alert |
| 11/23/2022 | Buy Now | 1771.92% | Goldman Sachs | Amit Hazan58% | $22 → $19 | Maintains | Buy | Get Alert |
| 11/09/2022 | Buy Now | 983.74% | JP Morgan | Allen Gong38% | $22 → $11 | Downgrade | Overweight → Neutral | Get Alert |
| 11/09/2022 | Buy Now | 3052.71% | DA Davidson | Linda Bolton Weiser53% | $31 → $32 | Maintains | Buy | Get Alert |
| 09/28/2022 | Buy Now | 2954.19% | DA Davidson | Linda Bolton Weiser53% | $30 → $31 | Maintains | Buy | Get Alert |
| 09/16/2022 | Buy Now | 2166.01% | Piper Sandler | Korinne Wolfmeyer47% | $20 → $23 | Maintains | Overweight | Get Alert |
| 09/16/2022 | Buy Now | 2855.67% | DA Davidson | Linda Bolton Weiser53% | $25 → $30 | Maintains | Buy | Get Alert |
| 08/16/2022 | Buy Now | 2067.49% | Goldman Sachs | Amit Hazan58% | $25 → $22 | Maintains | Buy | Get Alert |
| 08/10/2022 | Buy Now | 1870.44% | Piper Sandler | Korinne Wolfmeyer47% | $22 → $20 | Maintains | Overweight | Get Alert |
| 08/10/2022 | Buy Now | 2363.05% | DA Davidson | Linda Bolton Weiser53% | $24 → $25 | Maintains | Buy | Get Alert |
| 07/08/2022 | Buy Now | 2067.49% | Piper Sandler | Korinne Wolfmeyer47% | $24 → $22 | Maintains | Overweight | Get Alert |
| 06/30/2022 | Buy Now | 1870.44% | Canaccord Genuity | Kyle Rose67% | $22 → $20 | Maintains | Buy | Get Alert |
| 05/12/2022 | Buy Now | 2264.53% | DA Davidson | Linda Bolton Weiser53% | $35 → $24 | Maintains | Buy | Get Alert |
| 05/11/2022 | Buy Now | 2363.05% | Goldman Sachs | Amit Hazan58% | $29 → $25 | Maintains | Buy | Get Alert |
| 05/11/2022 | Buy Now | 2264.53% | Piper Sandler | Korinne Wolfmeyer47% | $26 → $24 | Maintains | Overweight | Get Alert |
| 04/28/2022 | Buy Now | 2461.58% | Piper Sandler | Korinne Wolfmeyer47% | $31 → $26 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Beauty Health (SKIN) stock?
The latest price target for Beauty Health (NASDAQ:SKIN) was reported by Canaccord Genuity on March 13, 2025. The analyst firm set a price target for $1.50 expecting SKIN to rise to within 12 months (a possible 47.78% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Beauty Health (SKIN)?
The latest analyst rating for Beauty Health (NASDAQ:SKIN) was provided by Canaccord Genuity, and Beauty Health maintained their hold rating.
When was the last upgrade for Beauty Health (SKIN)?
The last upgrade for The Beauty Health Co happened on March 20, 2023 when Exane BNP Paribas raised their price target to N/A. Exane BNP Paribas previously had an underperform for The Beauty Health Co.
When was the last downgrade for Beauty Health (SKIN)?
The last downgrade for The Beauty Health Co happened on November 15, 2023 when Jefferies changed their price target from $11 to $1.5 for The Beauty Health Co.
When is the next analyst rating going to be posted or updated for Beauty Health (SKIN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Beauty Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Beauty Health was filed on March 13, 2025 so you should expect the next rating to be made available sometime around March 13, 2026.
Is the Analyst Rating Beauty Health (SKIN) correct?
While ratings are subjective and will change, the latest Beauty Health (SKIN) rating was a maintained with a price target of $1.75 to $1.50. The current price Beauty Health (SKIN) is trading at is $1.01, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.